계정 가입
이미 존재한 계정
가입을 클릭하여 코인타임의 <a class="underline" href="#term-of-service">서비스 약관</a> 과 a class="underline" href="#privacy-policy">개인정보 보호 정책</a> . 에 동의함.
email 로 로그인
email 로 가입
사용자 이메일
수신함을 확인하세요
중의 링크를 통해 로그인 하세요
중의 링크를 통해 가입 하세요
Antios Therapeutics
company
About
Antios Therapeutics is a biopharmaceutical company developing innovative therapies for viral diseases.
- 11 - 50
Highlights
Details
- Last Funding Type
- Series B
- Last Funding Money Raised
- $75M
- Industries
- Biopharma,Biotechnology,Therapeutics
- Founded date
- Jan 1, 2018
- Number Of Employee
- 11 - 50
- Operating Status
- Active
Antios Therapeutics is a biopharmaceutical company devoted to developing innovative therapies for viral diseases. With an experienced and proven leadership team, the company is focused on the development of its oral drug candidate for potentially curative treatment of HBV infections.Antios Therapeutics was founded by Abel De La Rosa, Douglas Mayers, and Idean Marvasty.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$75M
Antios Therapeutics has raised a total of
$75M
in funding over 2 rounds. Their latest funding was raised on
Nov 3, 2021 from a Series B round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Nov 3, 2021 | Series B | $75M | 2 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
2
Antios Therapeutics is funded by 2 investors.
Heartland Healthcare Capital
and Avego Bioscience Capital
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
|
— | Series B |
|
|
— | Series B |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
